Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, May 2, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients
Life Sciences Times
-
May 1, 2026
Pharma
FDA Advisory Panel Backs AstraZeneca’s TRUQAP Combination for PTEN-Deficient Prostate Cancer
Life Sciences Times
-
May 1, 2026
Pharma
Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study
Life Sciences Times
-
April 30, 2026
Pharma
Newron Reports FDA Hold on New Enrollment at U.S. Sites in Schizophrenia Study
Life Sciences Times
-
April 30, 2026
Pharma
Verastem Oncology Launches Campaign for KRAS-Mutated Recurrent Ovarian Cancer Treatment
Life Sciences Times
-
April 30, 2026
Pharma
ChromaDex Announces Expansion of Pharmaceutical-Grade Niagen® IV and Injection Offerings to Additional Leading Wellness Clinics
Life Sciences Times
-
September 10, 2024
0
Pharma
Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan)
Life Sciences Times
-
September 6, 2024
0
Pharma
Vetter’s European Clinical Site Successfully Completes First 100 Aseptic Fills
Life Sciences Times
-
September 5, 2024
0
Pharma
IGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer’s Disease
Life Sciences Times
-
September 4, 2024
0
Pharma
Transforming the Future of Medicine with RNA-Based Therapies
Life Sciences Times
-
August 27, 2024
0
Pharma
Opna Bio Doses First Patient in Phase 1 Study in Multiple Myeloma with OPN-6602, an EP300/CBP Bromodomain Inhibitor
Life Sciences Times
-
August 26, 2024
0
Pharma
Pfizer Announces Top-Line Results of ABRYSVO® for RSV in Immunocompromised Adults
Life Sciences Times
-
August 12, 2024
0
Pharma
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate
Life Sciences Times
-
August 12, 2024
0
Pharma
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, involving Patients with...
Life Sciences Times
-
August 5, 2024
0
Pharma
Professional Pickleball Player James Ignatowich Partners With IBSA USA to Promote Licart®
Life Sciences Times
-
August 5, 2024
0
Pharma
Vertex Announces FDA Acceptance of New Drug Application for Suzetrigine for the Treatment of Moderate-to-Severe Acute Pain
Life Sciences Times
-
July 30, 2024
0
Pharma
BioAge Announces First Patient Dosed in the STRIDES Phase 2 Clinical Trial Evaluating Azelaprag as a Novel Treatment for Obesity in Combination with Tirzepatide
Life Sciences Times
-
July 29, 2024
0
1
...
32
33
34
...
91
Page 33 of 91
Most Read
Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board
May 1, 2026
SK Capital Completes Sale of Noramco Group Businesses to Siegfried
May 1, 2026
GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients
May 1, 2026
Seaport Therapeutics Prices Upsized IPO at $18 Per Share
May 1, 2026